Linked Life Data

3915320

Source:http://linkedlifedata.com/resource/pubmed/id/3915320

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
2
pubmed:dateCreated
1986-7-25
pubmed:abstractText
Chronic diuretic therapy in hypertensive patients may be associated with a reversible deterioration in glucose tolerance. There is evidence to suggest that beta-blocker monotherapy may cause a deterioration in glucose tolerance in patients with non-insulin-dependent diabetes mellitus but little information about the effects of chronic beta-blocker treatment in hypertensive patients with normal glucose metabolism. A prospective evaluation of the effects of propranolol monotherapy on glucose tolerance was performed in 13 nondiabetic hypertensive patients. One patient developed diabetes mellitus after 1 month of treatment. Of 11 patients, 4 had a 30% or greater increase in fasting glucose after 1 year of therapy and a significant increase in fasting, and 2-hour postglucose-load venous plasma glucose occurred in the 9 patients completing 18 months of treatment. Although the biologic significance of these changes is questionable, the development of hyperglycemia in a patient receiving beta blockers could represent a side effect of drug therapy.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Jun
pubmed:issn
0748-450X
pubmed:author
pubmed:issnType
Print
pubmed:volume
1
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
138-44
pubmed:dateRevised
2011-11-17
pubmed:meshHeading
pubmed:year
1985
pubmed:articleTitle
Glucose tolerance during chronic propranolol treatment.
pubmed:publicationType
Journal Article